Search research articles
Contact Us
Filters
Showing results (1-10 of 95) with videos related to
Page
of 10
Sort By:
Frontiers in Oncology
|
April 24, 2023
Editorial: Precision medicine in sarcomas: the road to an effective biomarker-driven-care strategy
Samia Arifi, Anastasia Constantinidou
Journal of Oncology Practice
|
March 11, 2016
Systemic Treatment of Liposarcomas: Light at the End of the Tunnel?
Anastasia Constantinidou, Ian Judson
Frontiers in Genetics
|
January 30, 2023
Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
Sotiris Loizides, Anastasia Constantinidou
Frontiers in Immunology
|
July 24, 2024
Tumor associated macrophages in breast cancer progression: implications and clinical relevance
Maria Stavrou, Anastasia Constantinidou
Breast (Edinburgh, Scotland)
|
October 22, 2011
Is there a case for anti-HER2 therapy without chemotherapy in early breast cancer?
Anastasia Constantinidou, Ian Smith
International Journal of Clinical Oncology
|
February 8, 2012
The efficacy of caffeine-potentiated chemotherapy in clear cell sarcoma
Robin L Jones, Anastasia Constantinidou
Journal of Surgical Oncology
|
December 2, 2017
Systemic therapy in retroperitoneal sarcoma management
Anastasia Constantinidou, Robin L Jones
Frontiers in Medicine
|
July 3, 2023
Patients' perspectives related to ethical issues and risks in precision medicine: a systematic review
Lawko Ahmed, Anastasia Constantinidou, Andreas Chatzittofis
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
November 20, 2019
Paraneoplastic Arthritides: Insights to Pathogenesis, Diagnostic Approach, and Treatment
Konstantinos Parperis, Anastasia Constantinidou, George Panos
Breast Care (Basel, Switzerland)
|
November 1, 2021
False Negativity of Targeted Axillary Dissection in Breast Cancer
George Kirkilesis, Anastasia Constantinidou, Michalis Kontos
Page
of 10
Search research articles
Search
Showing results (1-10 of 95) with videos related to
Sort By:
Page
of 10
Frontiers in Oncology
|
April 24, 2023
Editorial: Precision medicine in sarcomas: the road to an effective biomarker-driven-care strategy
Samia Arifi, Anastasia Constantinidou
Journal of Oncology Practice
|
March 11, 2016
Systemic Treatment of Liposarcomas: Light at the End of the Tunnel?
Anastasia Constantinidou, Ian Judson
Frontiers in Genetics
|
January 30, 2023
Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
Sotiris Loizides, Anastasia Constantinidou
Frontiers in Immunology
|
July 24, 2024
Tumor associated macrophages in breast cancer progression: implications and clinical relevance
Maria Stavrou, Anastasia Constantinidou
Breast (Edinburgh, Scotland)
|
October 22, 2011
Is there a case for anti-HER2 therapy without chemotherapy in early breast cancer?
Anastasia Constantinidou, Ian Smith
International Journal of Clinical Oncology
|
February 8, 2012
The efficacy of caffeine-potentiated chemotherapy in clear cell sarcoma
Robin L Jones, Anastasia Constantinidou
Journal of Surgical Oncology
|
December 2, 2017
Systemic therapy in retroperitoneal sarcoma management
Anastasia Constantinidou, Robin L Jones
Frontiers in Medicine
|
July 3, 2023
Patients' perspectives related to ethical issues and risks in precision medicine: a systematic review
Lawko Ahmed, Anastasia Constantinidou, Andreas Chatzittofis
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
November 20, 2019
Paraneoplastic Arthritides: Insights to Pathogenesis, Diagnostic Approach, and Treatment
Konstantinos Parperis, Anastasia Constantinidou, George Panos
Breast Care (Basel, Switzerland)
|
November 1, 2021
False Negativity of Targeted Axillary Dissection in Breast Cancer
George Kirkilesis, Anastasia Constantinidou, Michalis Kontos
Page
of 10